aap Implantate AG (CHIX:AAQ1D) EBIT: €-2.53 Mil (TTM As of Dec. 2025)


CHIX:AAQ1D aap Implantate AG CHIX:AAQ1D
42 GF Score
Price €3.15
GF Value €1.78
! 4 Warning Signs
View Full Analysis

What is aap Implantate AG EBIT?

aap Implantate AG CHIX:AAQ1D 42 EBIT is €-2.53 Mil as of Dec. 2025. GuruFocus rates CHIX:AAQ1D with a GF Score™ of 42/100 and a GF Value™ of €1.78. The stock has 4 warning signs investors should review.

aap Implantate AG's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was €-1.56 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was €-2.53 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. aap Implantate AG's annualized ROC % for the quarter that ended in Dec. 2025 was -28.85%. aap Implantate AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -53.65%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. aap Implantate AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -10.43%.


aap Implantate AG  (CHIX:AAQ1d) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

aap Implantate AG's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-3.144 * ( 1 - 0.99% )/( (11.355 + 10.222)/ 2 )
=-3.1128744/10.7885
=-28.85 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

aap Implantate AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-3.118/( ( (2.641 + max(3.901, 0)) + (2.166 + max(2.915, 0)) )/ 2 )
=-3.118/( ( 6.542 + 5.081 )/ 2 )
=-3.118/5.8115
=-53.65 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.576 + 3.743 + 0.34) - (1.554 + 0 + 1.204)
=3.901

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.298 + 3.966 + 0.231) - (2.126 + 0 + 1.454)
=2.915

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

aap Implantate AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=-2.534/24.306
=-10.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


aap Implantate AG EBIT Related Terms


aap Implantate AG EBIT Historical Data

* Premium members only.

The historical data trend for aap Implantate AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

aap Implantate AG EBIT Chart

aap Implantate AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.36 -3.24 -7.35 -3.06 -2.53

aap Implantate AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.53 -0.76 -2.30 -0.98 -1.56

CHIX:AAQ1D vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, aap Implantate AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


aap Implantate AG EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where aap Implantate AG's EV-to-EBIT falls into.


CHIX:AAQ1D
42GF Score
aap Implantate AG CHIX:AAQ1D
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

aap Implantate AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-2.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €-2.53 Mil mean?
aap Implantate AG (CHIX:AAQ1D) has a EBIT of €-2.53 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on aap Implantate AG.
Is aap Implantate AG's EBIT too high?
aap Implantate AG's current EBIT is €-2.53 Mil. Overall, aap Implantate AG has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does aap Implantate AG's EBIT compare to ABT and SYK?
aap Implantate AG's EBIT of €-2.53 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on aap Implantate AG. aap Implantate AG's current EBIT is €-2.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aap Implantate AG stock overvalued right now?
aap Implantate AG (CHIX:AAQ1D) has a current EBIT of €-2.53 Mil. The stock's GF Value™ is €1.78, compared to a current price of €3.15 — trading 76.7% above its estimated fair value. The current EBIT is €-2.53 Mil. aap Implantate AG's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For aap Implantate AG (CHIX:AAQ1D), the current EBIT is €-2.53 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is aap Implantate AG (CHIX:AAQ1D) Overvalued in 2026?

Based on GuruFocus' analysis, aap Implantate AG stock appears to be overvalued. The current stock price of €3.15 is trading 76.7% above its estimated GF Value™ of €1.78.

Key valuation signals for CHIX:AAQ1D:

  • EBIT: €-2.53 Mil
  • GF Value™: €1.78 vs. price of €3.15 (76.7% above fair value)
  • GF Score™: 42/100 with 4 warning signs

No single metric tells the full story. See the CHIX:AAQ1D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


aap Implantate AG Business Description

Other Exchanges 0N5A:UKAAQ1:Germany
Address Lorenzweg 5, Berlin, DEU, 12099
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
42GF Score

Get the complete analysis for CHIX:AAQ1D

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.15
Price
€1.78
GF Value